JAK inhibitors
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for JAK inhibitors, covering 2025-01-10 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis [Phase 2]